应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
03186 易方达生物医药
已收盘 08-25 15:42:31
15.100
+0.150
+1.00%
最高
15.090
最低
14.940
成交量
7.71万
今开
14.940
昨收
14.950
日振幅
1.00%
总市值
2,567万
流通市值
2,567万
总股本
170.00万
成交额
116.12万
换手率
4.54%
流通股本
170.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
mRNA癌症疫苗实现历史性突破 易方达生物医药ETF(03186)港美股双布局捕捉创新红利
智通财经 · 08-20
mRNA癌症疫苗实现历史性突破 易方达生物医药ETF(03186)港美股双布局捕捉创新红利
ETF异动 | 易方达生物医药ETF(03186)涨近8% Moderna癌症疫苗突破引爆生物医药板块
智通财经 · 08-20
ETF异动 | 易方达生物医药ETF(03186)涨近8% Moderna癌症疫苗突破引爆生物医药板块
ETF异动 | 易方达生物医药ETF(03186)涨超3% 国内外医药投融资景气度持续上行
智通财经 · 07-06
ETF异动 | 易方达生物医药ETF(03186)涨超3% 国内外医药投融资景气度持续上行
空池名单调整 | 易方达生物医药ETF(03186)进入新一期空池名单
智通财经 · 03-20
空池名单调整 | 易方达生物医药ETF(03186)进入新一期空池名单
港交所：易方达生物医药ETF(03186)3月23日起开始买卖及获准列入认可卖空指定证券
智通财经 · 03-20
港交所：易方达生物医药ETF(03186)3月23日起开始买卖及获准列入认可卖空指定证券
公司概况
公司名称：
易方达生物医药
所属市场：
SEHK
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"03186","market":"HK","secType":"STK","nameCN":"易方达生物医药","latestPrice":15.1,"timestamp":1787643751732,"preClose":14.95,"halted":0,"volume":77100,"delay":0,"changeRate":0.010033444816053536,"floatShares":1700000,"shares":1700000,"eps":0,"marketStatus":"已收盘","change":0.15,"latestTime":"08-25 15:42:31","open":14.94,"high":15.09,"low":14.94,"amount":1161237,"amplitude":0.010033,"askPrice":15.4,"askSize":100,"bidPrice":15.09,"bidSize":600,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":5,"adr":0,"listingDate":1774195200000,"exchange":"SEHK","adjPreClose":14.95,"nav":15.1925,"aum":25827287.998,"bidAskSpread":0,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":0.669736,"lotSize":100,"spreadScale":3,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03186/wiki","defaultTab":"wiki","newsList":[{"id":"2660020034","title":"mRNA癌症疫苗实现历史性突破 易方达生物医药ETF(03186)港美股双布局捕捉创新红利","url":"https://stock-news.laohu8.com/highlight/detail?id=2660020034","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660020034?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:45","pubTimestamp":1787215545,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月19日，Moderna与默沙东公布，个人化mRNA癌症疫苗联合Keytruda，在黑色素瘤三期试验期中分析达标。截至2026年8月20日，易方达生物医药ETF 是港交所上市生物医药主题ETF中，唯一同时配置港股及美股生物医药成分的产品。这些成份股的均衡配置，让该ETF能够捕捉医药板块的整体修复行情。本次mRNA癌症疫苗达标，再次说明医疗创新本身就是科技突破，而不只是防御型板块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03186","09688","02162","BK1588","159929","BK1583","BK1587","BK1161","06990","LU0196878994.USD","159646","BK1574","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043472","title":"ETF异动 | 易方达生物医药ETF(03186)涨近8% Moderna癌症疫苗突破引爆生物医药板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043472","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660043472?lang=zh_cn&edition=full","pubTime":"2026-08-20 10:00","pubTimestamp":1787191208,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，易方达生物医药ETF涨近8%，截至发稿，涨7.7%，报15.8港元，成交额264.21万港元。消息面上，因首个“mRNA个性化癌症疫苗”三期试验成功，隔夜疫苗巨头Moderna股价飙涨177%，引爆生物医药板块，纳斯达克生物科技指数大涨6.4%，创下六年来最大涨幅；今早港股多只相关概念股亦大涨超50%。公开资料显示，易方达生物医药ETF跟踪Solactive生物医药精选指数，精选港美上市生物医药公司，一站覆盖美股管线深度与中国成长红利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","FDN","BK4581","161726","399441","BK4585","BK4588","03186","XBI","BK4550","159929"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649107306","title":"ETF异动 | 易方达生物医药ETF(03186)涨超3% 国内外医药投融资景气度持续上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2649107306","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649107306?lang=zh_cn&edition=full","pubTime":"2026-07-06 11:20","pubTimestamp":1783308051,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，易方达生物医药ETF盘中涨超3%，截至发稿，涨2.03%，报15.05港元，成交额125.78万港元。值得一提的是，当前国内外医药投融资景气度持续上行。据悉，易方达生物医药ETF紧密追踪Solactive生物医药精选指数，该指数是从港股和美股市场中精选100家生物制药公司作为成份股，覆盖中国、美国、欧洲、以色列、瑞士、日本等地，其中香港指数组成部分的总权重固定为指数总权重的65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","FDN","159938","09939","03186","BK4585","BK4588","BK4550","BK1515","159929","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620172780","title":"空池名单调整 | 易方达生物医药ETF(03186)进入新一期空池名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2620172780","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2620172780?lang=zh_cn&edition=full","pubTime":"2026-03-20 19:00","pubTimestamp":1774004448,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港交所于3月20日调整认可沽空指定证券名单，易方达生物医药ETF(03186)进入认可沽空指定证券名单。生效日期为3月23日。具体名单如下：","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620780986","title":"港交所：易方达生物医药ETF(03186)3月23日起开始买卖及获准列入认可卖空指定证券","url":"https://stock-news.laohu8.com/highlight/detail?id=2620780986","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2620780986?lang=zh_cn&edition=full","pubTime":"2026-03-20 18:53","pubTimestamp":1774003989,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月20日，港交所发布通告称，易方达(香港)Solactive生物医药精选指数ETF(03186)已获香港证券及期货事务监察委员会认可为集体投资计划并预计于2026年3月23日(星期一)开始在香港交易所买卖及获准列入认可卖空指定证券。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HEXmain","03186","161027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.024},{"period":"3month","weight":0.0506},{"period":"6month","weight":-0.0033},{"period":"ytd","weight":-0.0033}],"compareEarnings":[{"period":"1week","weight":0.0025},{"period":"1month","weight":0.0222},{"period":"3month","weight":-0.0032},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.007},{"period":"ytd","weight":-0.0044}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.06567},{"month":2,"riseRate":0.5,"avgChangeRate":0.018004},{"month":3,"riseRate":0,"avgChangeRate":-0.083391},{"month":4,"riseRate":0.4,"avgChangeRate":0.026605},{"month":5,"riseRate":0.4,"avgChangeRate":-0.028035},{"month":6,"riseRate":0.6,"avgChangeRate":0.072048},{"month":7,"riseRate":0.2,"avgChangeRate":-0.079396},{"month":8,"riseRate":0.4,"avgChangeRate":-0.001032},{"month":9,"riseRate":0,"avgChangeRate":-0.069025},{"month":10,"riseRate":0.6,"avgChangeRate":-0.039313},{"month":11,"riseRate":0.8,"avgChangeRate":0.094532},{"month":12,"riseRate":0.6,"avgChangeRate":-0.000028}],"exchange":"SEHK","name":"易方达生物医药","nameEN":"EFUND BIOPHAR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易方达生物医药(03186)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易方达生物医药(03186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易方达生物医药,03186,易方达生物医药股票,易方达生物医药股票老虎,易方达生物医药股票老虎国际,易方达生物医药行情,易方达生物医药股票行情,易方达生物医药股价,易方达生物医药股市,易方达生物医药股票价格,易方达生物医药股票交易,易方达生物医药股票购买,易方达生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易方达生物医药(03186)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易方达生物医药(03186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}